Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial
- PMID: 33545170
- DOI: 10.1016/j.ophtha.2021.01.026
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial
Comment in
-
Reply.Ophthalmology. 2021 Dec;128(12):e215-e217. doi: 10.1016/j.ophtha.2021.07.011. Epub 2021 Aug 23. Ophthalmology. 2021. PMID: 34446302 No abstract available.
-
Re: Saxena et al.: Atropine for treatment of childhood myopia in India: multicentric randomized trial (Ophthalmology. 2021;128:1367-1369).Ophthalmology. 2021 Dec;128(12):e214-e215. doi: 10.1016/j.ophtha.2021.08.003. Epub 2021 Aug 24. Ophthalmology. 2021. PMID: 34452762 No abstract available.
-
Re: Saxena et al.: Atropine for the treatment of childhood myopia in India: multicentric randomized trial. (Ophthalmology. 2021;128:1367-1369).Ophthalmology. 2022 May;129(5):e60. doi: 10.1016/j.ophtha.2021.07.010. Epub 2022 Feb 17. Ophthalmology. 2022. PMID: 35184893 No abstract available.
-
Reply.Ophthalmology. 2022 May;129(5):e60-e61. doi: 10.1016/j.ophtha.2022.01.024. Epub 2022 Feb 17. Ophthalmology. 2022. PMID: 35184894 No abstract available.